OtherCase Studies

Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping

Mingyan Cao, Wenjun (David) Mo, Anthony Shannon, Ziping Wei, Michael Washabaugh and Patricia Cash
PDA Journal of Pharmaceutical Science and Technology April 2016, pdajpst.2015.006239; DOI: https://doi.org/10.5731/pdajpst.2015.006239

Article Information

pdajpst.2015.006239
DOI 
https://doi.org/10.5731/pdajpst.2015.006239
PubMed 
27091886
Published By 
Parenteral Drug Association (PDA)
Print ISSN 
1079-7440
Online ISSN 
1948-2124
History 
  • Received October 21, 2015
  • Accepted March 31, 2016
  • Published online April 18, 2016.

Article Versions

Copyright & Usage 
Copyright © 2016, Parenteral Drug Association

Author Information

  1. Mingyan Cao1 (caom{at}medimmune.com),
  2. Wenjun (David) Mo2 (wenjundavidmo{at}163.com),
  3. Anthony Shannon1 (shannona{at}medimmune.com),
  4. Ziping Wei3 (wei_ziping{at}yahoo.com),
  5. Michael Washabaugh4 (michael.washabaugh{at}theraproteins.com) and
  6. Patricia Cash1,5 (cashp{at}medimmune.com)
  1. 1 MedImmune Inc.;
  2. 2 Teruisi Pharmaceutical Inc;
  3. 3 Novavax Inc.;
  4. 4 TheraProteins Inc.
  1. ↵* Corresponding author; email: cashp{at}medimmune.com

Cited By...

Back to top

In This Issue

Download PDF
Article Alerts
Email Article
Citation Tools
Qualification of a Quantitative Method for Monitoring Aspartate Isomerization of a Monoclonal Antibody by Focused Peptide Mapping
Mingyan Cao, Wenjun (David) Mo, Anthony Shannon, Ziping Wei, Michael Washabaugh, Patricia Cash
PDA Journal of Pharmaceutical Science and Technology Apr 2016, pdajpst.2015.006239; DOI: 10.5731/pdajpst.2015.006239
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords